You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Patent: 10,029,015


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,029,015
Title:Hydrogel formulations
Abstract: A polymeric prodrug composition including a hydrogel, a biologically active moiety and a reversible prodrug linker. The prodrug linker covalently links the hydrogel and the biologically active moiety at a position and the hydrogel has a plurality of pores with openings on its surface. The diameter of the pores is larger than that of the biologically active moiety at least at all points of the pore between at least one of the openings and the position of the biologically active moiety.
Inventor(s): Hersel; Ulrich (Heidelberg/Hanschuhsheim, DE), Rau; Harald (Heidelberg, DE), Schnepf; Robert (Heidelberg/Dossenheim, DE), Vetter; Dirk (Heidelberg/Neuenheim, DE), Wegge; Thomas (Heidelberg/Ziegelhausen, DE)
Assignee: ASCENDIS PHARMA A/S (Hellrup, DK)
Application Number:14/707,464
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of United States Patent 10,029,015: A Comprehensive Analysis

Introduction

Patent analysis is a crucial aspect of intellectual property management, especially when it comes to understanding the scope and claims of a specific patent. This article will delve into the details of United States Patent 10,029,015, examining its claims, the patent landscape, and the implications for innovators and patent practitioners.

Patent Overview

United States Patent 10,029,015, while not explicitly detailed in the provided sources, can be analyzed using general principles of patent law and analytics.

Invention Description

To begin, it is essential to understand the invention described in the patent. This involves a thorough review of the patent's abstract, detailed description, and drawings. The invention could pertain to any field, such as technology, pharmaceuticals, or engineering, and its description will outline the novel aspects and improvements it offers.

Claims Analysis

The claims section of a patent is the most critical part, as it defines the scope of protection granted by the patent. Here are some key points to consider:

Independent and Dependent Claims

  • Independent claims stand alone and define the invention without reference to other claims. They are broad and encompass the core aspects of the invention.
  • Dependent claims, on the other hand, refer back to and further limit the independent claims, often adding specific details or features[3].

Claim Construction

Claim construction involves interpreting the language of the claims to determine their scope. This process is crucial for understanding what is protected by the patent and what is not. It often involves analyzing the claim language in the context of the specification and the prosecution history of the patent[3].

Subject Matter Eligibility

Given the recent updates in patent law, particularly the 2024 USPTO guidance on AI-related inventions, it is important to assess whether the claims of the patent meet the subject matter eligibility criteria.

Judicial Exceptions and Practical Applications

The USPTO guidance emphasizes the importance of integrating judicial exceptions into practical applications. For a claim to be patent-eligible, it must go beyond mere abstract ideas or routine data processing. It must include additional elements that impose meaningful limits and provide a concrete technological improvement[1].

AI-Assisted Inventions

If the invention described in the patent involves AI, the method of invention development, including the use of AI, does not impact subject matter eligibility. The focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Patent Landscape Analysis

Analyzing the patent landscape involves understanding the broader context in which the patent exists. Here are some key aspects:

Claim Coverage Matrix

A Claim Coverage Matrix can help identify which patents and claims are actively protecting the intellectual property related to the invention. This matrix categorizes patents by claims and scope concepts, providing a powerful tool for filtering and analyzing large numbers of patent claims[3].

Scope Concepts and Claim Charts

Scope concepts link claims on similar patents, allowing for efficient analysis of the patent landscape. Claim charts generated by tools like ClaimScape® can be reviewed by technical experts to determine whether a particular scope concept is applicable to a target product or method. This helps in identifying gaps in current coverage and highlighting future design opportunities[3].

Practical Applications and Real-World Benefits

Demonstrating the real-world applications of the claimed method or system is crucial for bolstering the argument for patent eligibility.

Case Study: Speech Recognition System

For example, if a claim involves a speech recognition system, specifying the use of separated audio components in a real-time application to enhance the accuracy of voice commands in hands-free environments would provide a practical application. This additional step shows how the abstract idea is transformed into a specific, practical application that offers clear benefits, such as improved accuracy in speech recognition systems[1].

Legal and Policy Considerations

The legal and policy framework surrounding patents is constantly evolving.

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could impact how patent disputes are resolved. Such a court would address issues associated with the cost and complexity of patent litigation, potentially making it more accessible for smaller entities to enforce their patent rights[5].

Key Takeaways

  • Claims Analysis: The claims section is critical and must be carefully constructed to ensure the invention is adequately protected.
  • Subject Matter Eligibility: Claims must integrate judicial exceptions into practical applications to meet patent eligibility criteria.
  • Patent Landscape: Analyzing the patent landscape using tools like Claim Coverage Matrix and Claim Charts helps in understanding the broader context and identifying gaps or opportunities.
  • Practical Applications: Demonstrating real-world applications and benefits is essential for patent eligibility.
  • Legal Considerations: Staying updated with legal and policy changes, such as the potential for a small claims patent court, is vital for effective patent management.

FAQs

Q: What is the importance of claim construction in patent analysis?

A: Claim construction is crucial as it determines the scope of protection granted by the patent, helping to understand what is protected and what is not.

Q: How does the 2024 USPTO guidance impact AI-related inventions?

A: The guidance clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, focusing on the claimed invention itself rather than the method of invention development.

Q: What is a Claim Coverage Matrix, and how is it used?

A: A Claim Coverage Matrix categorizes patents by claims and scope concepts, providing a tool for filtering and analyzing large numbers of patent claims to identify gaps or opportunities in intellectual property protection.

Q: Why are practical applications important for patent eligibility?

A: Practical applications transform abstract ideas into specific, practical uses that provide tangible benefits, which is essential for meeting patent eligibility criteria.

Q: What is the potential impact of a small claims patent court on patent litigation?

A: A small claims patent court could make patent litigation more accessible and less costly for smaller entities, simplifying the process of enforcing patent rights.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. ALLERGAN USA, INC. v. MSN LABORATORIES PRIVATE LTD. - CAFC
  3. Patent Analytics - Schwegman
  4. Coagulation factor Xa inhibitor - Patent JP-2004503563-A - PubChem
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe

Details for Patent 10,029,015

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 January 15, 1974 10,029,015 2024-07-05
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 December 27, 1984 10,029,015 2024-07-05
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 February 15, 1985 10,029,015 2024-07-05
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 February 16, 1990 10,029,015 2024-07-05
Bel-mar Laboratories, Inc. CHORIONIC GONADOTROPIN chorionic gonadotropin Injection 017054 March 26, 1974 10,029,015 2024-07-05
Ferring Pharmaceuticals Inc. A.P.L. chorionic gonadotropin For Injection 017055 December 13, 1974 10,029,015 2024-07-05
Fresenius Kabi Usa, Llc CHORIONIC GONADOTROPIN chorionic gonadotropin For Injection 017067 March 05, 1973 10,029,015 2024-07-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.